Recombinant Vibrio vulnificus UPF0325 protein VV2560 (VV2560)

Shipped with Ice Packs
In Stock

Description

General Information

Recombinant Vibrio vulnificus UPF0325 protein VV2560 (VV2560) is a protein produced in various expression systems, including yeast, E. coli, baculovirus, and mammalian cells . It is derived from the bacterium Vibrio vulnificus, an opportunistic pathogen known to cause primary septicemia and wound infections in humans .

Characteristics

  • Source: VV2560 can be produced in different host organisms, each offering unique advantages in terms of post-translational modifications and protein folding . The sources include:

    • Yeast

    • E. coli

    • Baculovirus

    • Mammalian cells

  • Purity: Recombinant VV2560 is manufactured to high purity standards, making it suitable for research and development applications .

  • Biotinylation: A specific form of recombinant VV2560 is biotinylated using the AviTag-BirA technology. This involves the E. coli biotin ligase (BirA) covalently attaching biotin to the 15 amino acid AviTag peptide, allowing for specific binding and detection in various assays .

Function and Significance

The UPF0325 protein VV2560 is of unknown function, though studies suggest that it may play a role in virulence and pathogenesis within Vibrio species . Several Vibrio vulnificus proteins have been identified as virulence factors. Examples include:

  • Flagellins: V. vulnificus possesses multiple flagellin genes (flaA, -B, -C, -D, -E, and -F), with FlaB being a crucial component of the flagellum. FlaB has mucosal adjuvant activity and induces protective immunity by activating innate immune responses via the TLR5 signaling pathway .

  • OmpU: OmpU is a major outer membrane protein of V. vulnificus that binds to fibronectin, facilitating the adherence of the bacteria to host cells. Mutants lacking OmpU show reduced adherence and cytotoxicity .

  • MARTX toxin: V. vulnificus secretes the multifunctional-autoprocessing repeats-in-toxin (MARTX) toxin, which contains a cysteine protease domain (CPD) responsible for activating the toxin by cleaving the toxin precursor and releasing mature toxin fragments .

Research Applications

While the specific function of VV2560 remains under investigation, recombinant Vibrio vulnificus UPF0325 protein VV2560 (VV2560) is likely used in:

  • Antibody Production: For raising antibodies to study protein function and localization.

  • Binding Assays: To identify interacting partners and understand its role in cellular processes.

  • Structural Studies: To determine its three-dimensional structure and gain insights into its function .

Availability

Recombinant VV2560 is commercially available from suppliers such as Cusabio . It is offered in various forms and sizes, with specific details available upon inquiry.

Data Table

FeatureDescription
Protein NameRecombinant Vibrio vulnificus UPF0325 protein VV2560 (VV2560)
Source OrganismVibrio vulnificus
Expression SystemsYeast, E. coli, Baculovirus, Mammalian cell
Available ModificationsAvi-tag Biotinylated (via E. coli biotin ligase BirA)
PurityHigh purity (specific details available from supplier)
ApplicationsAntibody production, binding assays, structural studies, investigating protein function and its role in virulence and pathogenesis.
Commercial AvailabilityAvailable from suppliers like Cusabio. Product codes include CSB-YP762679VCQ, CSB-EP762679VCQ, CSB-EP762679VCQ-B, CSB-BP762679VCQ, CSB-MP762679VCQ .
Related Virulence FactorsFlagellins (FlaB), OmpU, MARTX toxin

Ligand Binding and Proteolytic Stability

Research indicates that ligand binding influences the proteolytic stability of Vibrio LuxR/HapR homologs like SmcR in V. vulnificus . For instance, PTSP, a thiophenesulfonamide compound, binds to the ligand binding pocket of SmcR, promoting protein degradation by the ClpAP protease . This mechanism suppresses downstream gene expression, affecting virulence gene expression in Vibrio pathogens .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a guideline for your reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms maintain stability for 12 months under the same conditions.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is finalized during production. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
VV2560UPF0325 protein VV2560
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-127
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Vibrio vulnificus (strain YJ016)
Target Names
VV2560
Target Protein Sequence
MYPHLTGLGI HDPSQIERYS LRQEAHKDVL KIYFHKQKGE FFAKSVKFKY PRQVKNVLVD SGSHQYKEVT EINRNLTLVI DELNKITKPP KQEDVDIKQK ILTDLKHLEK VVASKIAEIE ADLEKLK
Uniprot No.

Q&A

What is UPF0325 protein VV2560 and what organism does it originate from?

VV2560 is a protein classified in the UPF0325 protein family that originates from Vibrio vulnificus strain YJ016. The "UPF" designation (Uncharacterized Protein Family) indicates that its precise biological function remains to be fully elucidated. According to the available data, VV2560 is a full-length protein consisting of 127 amino acids . The protein has been assigned the UniProt accession number Q7MIF7, which serves as its unique identifier in protein databases .

What expression systems are currently available for producing recombinant VV2560?

Based on available research materials, recombinant VV2560 can be produced using at least two different expression systems:

  • Yeast-based expression system (product code CSB-YP762679VCQ)

  • E. coli-based expression system (product code CSB-EP762679VCQ)

Each system offers distinct advantages for protein production. The yeast system may provide certain eukaryotic post-translational modifications, while the E. coli system typically allows for higher protein yields and more straightforward purification protocols. The choice between these systems would depend on specific research requirements, including the need for particular protein conformations or modifications.

What experimental design would be most appropriate for studying the function of VV2560?

When investigating an uncharacterized protein like VV2560, implementing a Completely Randomized Design (CRD) would be appropriate for initial experiments, particularly when working with homogeneous experimental material . The CRD approach offers flexibility in the number of treatments or replications that can be used, allowing researchers to tailor their experimental setup to the specific research question .

For more complex experimental scenarios involving multiple variables (such as different expression systems, buffer conditions, and environmental factors), researchers might consider a Latin Square Design. This approach would be particularly valuable when needing to control for three factors simultaneously, as it reduces the total number of experimental units required compared to a full factorial design while still maintaining experimental validity .

A comprehensive experimental approach should include:

  • Sequence analysis and structure prediction

  • Comparative expression analysis under different conditions

  • Protein-protein interaction studies

  • Phenotypic analysis of knockout/knockdown mutants

  • Functional assays based on predicted domains

How should researchers optimize protein expression conditions for VV2560?

Optimization of VV2560 expression requires systematic testing of multiple parameters. A structured experimental design approach is recommended, beginning with small-scale expression trials before scaling up. The experimental units should be divided appropriately and treatments assigned randomly to ensure statistical validity .

Key factors to optimize include:

ParameterVariables to TestConsiderations
Expression hostE. coli vs. YeastBased on available systems
Induction conditionsTemperature, inducer concentration, timingAffects folding and solubility
Growth mediaRich vs. minimal, supplementsImpacts cell density and protein yield
Cell lysis methodSonication, chemical, enzymaticInfluences protein activity retention
Purification strategyTag selection, buffer optimizationAffects purity and yield

For each optimization step, sufficient replication is essential (typically 3-5 replicates) to ensure statistical significance. Data should be analyzed using appropriate statistical methods such as ANOVA to determine the optimal conditions .

What are the recommended storage and handling protocols for recombinant VV2560?

According to product documentation, the stability of recombinant VV2560 depends on several factors including storage state, buffer composition, temperature, and the intrinsic stability of the protein itself . Recommended storage and handling protocols include:

  • Long-term storage:

    • Liquid form: -20°C to -80°C for up to 6 months

    • Lyophilized form: -20°C to -80°C for up to 12 months

  • Working aliquots:

    • Store at 4°C for no more than one week

    • Avoid repeated freeze-thaw cycles

  • Reconstitution procedure:

    • Briefly centrifuge vial prior to opening

    • Reconstitute in deionized sterile water to 0.1-1.0 mg/mL

    • Add glycerol to 5-50% (50% recommended) final concentration

    • Aliquot for long-term storage

These handling guidelines are critical for maintaining protein integrity and experimental reproducibility. The experimental design for a stability study would require systematic testing of various storage conditions with replicated samples analyzed at multiple time points.

How can researchers effectively analyze structural features of VV2560?

A comprehensive structural analysis of VV2560 requires a multi-method approach:

  • Computational analysis:

    • Secondary structure prediction

    • Homology modeling based on related UPF0325 family proteins

    • Molecular dynamics simulations to predict stability and potential binding sites

  • Experimental structure determination:

    • X-ray crystallography (requires successful crystallization)

    • Nuclear Magnetic Resonance (NMR) for solution structure

    • Small-angle X-ray scattering (SAXS) for low-resolution envelope

  • Functional domain mapping:

    • Limited proteolysis to identify structured domains

    • Mutagenesis of conserved residues

    • Chimeric protein construction with related proteins

The experimental design for structural studies should incorporate appropriate controls and replication to ensure reliability of the results . For instance, when comparing different structural variants, a Randomized Block Design might be appropriate to control for batch-to-batch variation in protein preparation.

What methods can be used to elucidate potential functions of this uncharacterized protein?

For an uncharacterized protein like VV2560, a systematic approach to functional characterization should include:

  • Genomic context analysis:

    • Examination of neighboring genes in the Vibrio vulnificus genome

    • Identification of potential operons or functionally related gene clusters

  • Comparative genomics:

    • Identification of homologs in related bacterial species

    • Correlation of presence/absence with specific phenotypes

  • Experimental function determination:

    • Generation of knockout mutants and phenotypic characterization

    • Transcriptomic/proteomic profiling of knockout vs. wild-type

    • High-throughput substrate screening if enzymatic activity is suspected

  • Protein-protein interaction studies:

    • Pull-down assays using tagged recombinant VV2560

    • Bacterial two-hybrid screening

    • In vivo crosslinking followed by mass spectrometry

Each experimental approach should be designed with proper controls and sufficient replication, using appropriate statistical designs such as CRD for initial screening and more structured designs for focused studies . The data generated should be analyzed using statistical methods appropriate for the experimental design, such as ANOVA for comparing multiple conditions.

How can researchers design experiments to study potential post-translational modifications of VV2560?

When investigating potential post-translational modifications (PTMs) of VV2560, researchers should implement a systematic experimental approach:

  • Prediction of potential PTMs:

    • Computational analysis of sequence for modification motifs

    • Comparison with known modified proteins in the UPF0325 family

  • Experimental detection methods:

    • Mass spectrometry (MS) approaches:

      • Bottom-up proteomics with PTM-specific enrichment

      • Top-down proteomics for intact protein analysis

      • Targeted MS methods for specific modifications

  • Expression system considerations:

    • Comparison of VV2560 expressed in different systems:

      • E. coli (limited PTM capabilities)

      • Yeast (more extensive eukaryotic PTMs)

      • Native expression in Vibrio vulnificus (authentic modifications)

  • Functional impact assessment:

    • Site-directed mutagenesis of potential modification sites

    • Comparison of modified vs. unmodified protein activities

The experimental design should incorporate appropriate randomization and replication, with statistical analysis methods such as ANOVA to determine significant differences between treatment groups . A Latin Square Design might be particularly useful when comparing multiple expression systems and analytical methods simultaneously.

What quality control parameters should be monitored when working with recombinant VV2560?

Effective quality control for recombinant VV2560 requires monitoring several critical parameters:

  • Purity assessment:

    • SDS-PAGE analysis (specification: >85% purity)

    • Size exclusion chromatography to detect aggregates

    • Reverse-phase HPLC for additional purity verification

  • Identity confirmation:

    • Western blot with specific antibodies

    • Peptide mass fingerprinting

    • N-terminal sequencing

  • Structural integrity:

    • Circular dichroism to assess secondary structure

    • Fluorescence spectroscopy for tertiary structure assessment

    • Dynamic light scattering for aggregation analysis

  • Batch consistency:

    • Lot-to-lot comparison using standardized analytical methods

    • Reference standard comparison

    • Trend analysis for quality attributes over time

Each batch of recombinant VV2560 should be rigorously tested against these parameters before use in experiments. Statistical methods such as ANOVA can be used to analyze batch-to-batch variation and establish acceptance criteria .

What are common challenges in purifying VV2560 and how can they be addressed?

Based on general principles of recombinant protein purification and the available information about VV2560, researchers may encounter several challenges:

ChallengePossible CausesRecommended Solutions
Low expression yieldCodon bias, protein toxicityOptimize codon usage, use inducible promoters, lower expression temperature
Inclusion body formationRapid expression, misfoldingReduce induction temperature, co-express chaperones, optimize solubility tags
Co-purification of contaminantsNon-specific binding to purification resinIncrease wash stringency, add competitive agents, use multiple purification steps
Protein degradationProtease activity, protein instabilityAdd protease inhibitors, reduce purification time, optimize buffer conditions
Loss of activityImproper folding, missing cofactorsScreen buffer conditions, add potential cofactors, verify structure integrity

Experimental approaches to address these challenges should be designed with appropriate controls and replication. For example, when optimizing purification conditions, a factorial design might be employed to systematically test combinations of buffer components, with the results analyzed by ANOVA to identify significant effects .

How can researchers ensure experimental reproducibility when working with VV2560?

Ensuring reproducibility in experiments involving VV2560 requires rigorous attention to detail and standardized procedures:

  • Material standardization:

    • Use consistent protein sources with documented specifications

    • Thoroughly characterize each new batch before use

    • Maintain detailed records of protein lot numbers and preparation methods

  • Experimental design considerations:

    • Implement appropriate randomization techniques

    • Include sufficient biological and technical replicates

    • Utilize blocking factors when necessary to control for known sources of variation

    • Pre-register experimental protocols and analysis plans

  • Protocol documentation:

    • Maintain detailed standard operating procedures (SOPs)

    • Record all experimental parameters precisely

    • Document any deviations from established protocols

  • Data management:

    • Implement systematic data organization and backup procedures

    • Use consistent naming conventions and metadata

    • Employ electronic laboratory notebooks with version control

  • Statistical considerations:

    • Determine sample sizes through power analysis

    • Apply appropriate statistical methods based on experimental design

    • Report all statistical details including test selection rationale

By implementing these practices, researchers can significantly improve the reproducibility of their experiments with VV2560 and enhance the reliability of their findings.

What statistical approaches are appropriate for analyzing functional studies of VV2560?

The choice of statistical methods for analyzing VV2560 functional studies depends on the experimental design and research questions:

  • For comparison between two conditions:

    • Student's t-test (parametric data)

    • Mann-Whitney U test (non-parametric data)

    • Sample size determination should be based on power analysis

  • For multiple condition comparisons:

    • One-way ANOVA followed by appropriate post-hoc tests (e.g., Tukey's HSD)

    • Kruskal-Wallis test for non-parametric data

    • Control for multiple comparisons using methods such as Bonferroni or FDR

  • For complex experimental designs:

    • Two-way or three-way ANOVA for factorial designs

    • Mixed-effects models for designs with both fixed and random factors

    • Latin Square Design analysis for three-factor studies

  • For time-course experiments:

    • Repeated measures ANOVA

    • Linear mixed models

    • Time series analysis methods

Each statistical approach should be selected based on the experimental design used, with attention to assumptions such as normality and homogeneity of variance. The analysis should be performed using validated statistical software and results reported with appropriate measures of uncertainty.

How should researchers interpret contradictory results when studying VV2560?

When confronted with contradictory results in VV2560 research, a systematic approach to reconciliation is essential:

  • Methodological assessment:

    • Compare experimental protocols in detail

    • Review differences in protein sources (E. coli vs. yeast expression)

    • Examine differences in buffer compositions and experimental conditions

    • Evaluate the statistical power of each study

  • Biological context considerations:

    • Assess potential strain differences in Vibrio vulnificus

    • Consider environmental or physiological factors that might influence protein function

    • Evaluate potential post-translational modifications in different expression systems

  • Resolution strategies:

    • Design critical experiments that directly address contradictions

    • Use orthogonal methods to test the same hypothesis

    • Implement blinded experimental procedures to reduce bias

    • Conduct meta-analysis if multiple studies exist

  • Statistical approaches:

    • Use ANOVA to identify sources of variation across studies

    • Implement Bayesian methods to integrate prior knowledge with new data

    • Conduct sensitivity analyses to identify critical parameters

Contradictory results often reveal important contextual dependencies of protein function and can lead to deeper understanding when properly investigated rather than dismissed.

What are promising approaches for determining the physiological role of VV2560 in Vibrio vulnificus?

Understanding the physiological role of VV2560 in its native organism requires a multifaceted research approach:

  • Genetic manipulation studies:

    • Generation of VV2560 knockout mutants in Vibrio vulnificus

    • Complementation studies to confirm phenotypes

    • Conditional expression systems to study essentiality

  • Phenotypic characterization:

    • Growth studies under various environmental conditions

    • Stress response testing (oxidative, osmotic, temperature)

    • Virulence assays if pathogenicity is suspected

  • Systems biology approaches:

    • Transcriptomic profiling of wildtype vs. knockout strains

    • Metabolomic analysis to identify biochemical pathways affected

    • Protein interaction network mapping

  • Comparative genomics:

    • Analysis of VV2560 conservation across Vibrio species

    • Correlation of gene presence with specific phenotypes

    • Evolutionary analysis to identify selective pressures

The experimental design for these studies should incorporate appropriate controls and sufficient replication to ensure statistical validity . The choice between CRD and more complex designs would depend on the specific research question and the nature of the experimental system.

How can structural studies of VV2560 contribute to understanding the UPF0325 protein family?

Structural characterization of VV2560 can provide significant insights into the broader UPF0325 protein family:

  • Structure-function relationships:

    • Identification of conserved structural motifs across the family

    • Mapping of potential active sites or binding interfaces

    • Correlation of structural features with known functional data

  • Evolutionary insights:

    • Structural comparison with homologs from different species

    • Identification of conserved vs. variable regions

    • Reconstruction of evolutionary pathways within the protein family

  • Practical applications:

    • Structure-based prediction of function for other UPF0325 members

    • Design of targeted mutations to test functional hypotheses

    • Development of specific inhibitors or modulators if relevant

  • Technical approaches:

    • X-ray crystallography of VV2560 alone and in complexes

    • NMR studies for dynamic regions

    • Computational modeling validated by experimental data

The design of structural studies should consider various protein constructs, buffer conditions, and crystallization parameters. Statistical analysis of diffraction data quality and structure validation metrics would be essential for ensuring reliable structural models .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.